Administration of long-term tamoxifen therapy modifies the plasma lipoprotein-lipid concentration and lipid transfer protein I activity in postmenopausal women with breast cancer

Journal of Pharmaceutical Sciences

Volumn 86, Issue 7, 1997, Pages 876-879

  Wasan, Kishor M ^a   Ramaswamy, Manisha ^a   Haley, Jondean ^a   Dunn, Bruce P ^b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b BRITISH COLUMBIA CANCER AGENCY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; LIPID TRANSFER PROTEIN; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; TAMOXIFEN; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ADULT; ARTICLE; BREAST CANCER; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY RISK; DRUG EFFECT; FEMALE; HUMAN; LIPID TRANSPORT; LIPOPROTEIN BLOOD LEVEL; MAINTENANCE THERAPY; ORAL DRUG ADMINISTRATION; POSTMENOPAUSE;

EID: 0030852666     PISSN: 00223549     EISSN: None     Source Type: Journal    
DOI: 10.1021/js970097w     Document Type: Article

References (29)

1. Legha, S. S. Ann. Intern. Med. 1988, 109, 219-228.
2. Cuzick, J; Wang, D. Y.; Bulbrook, R. D. Lancet 1986, 1, 83-86.
3. Wingard D. L. Annu. Rev. Public Health 1984, 5, 433-458.
4. Bush, T. L.; Barrett-Connor, E. Epidemiol. Rev. 1985, 7, 49-58.
5. Kinosian, B.; Glick, H.; Garland, G.Ann. Intern. Med. 1994, 121, 641-647.
6. Folsom, A. R.; Kaye, S. A.; Sellers, T. A.; et al. J. Am. Med. Assoc. 1993, 269, 483-487.
7. Rossner, S.; Wallgren, A. Atherosclerosis 1984, 52, 339-346.
8. Grey, A. B.; Stapleton, J. P.; Evans, M. C.; Reid, I. R. J. Clin. Endocrinol. Metab. 1995, 80, 3191-3195.
9. Bagdade, J. D.; Wolter, J.; Subbaiah, P. V.; Ryan, W. J. Clin. Endocrinol. Metab. 1990, 70, 1132-1135.
10. Powles, T. J.; Hardy, J. R.; Ashley, S. E.; et al. Br. J. Cancer. 1989, 60, 126-131.
11. Wiseman, H.; Paganga, G.; Rice-Evans, C.; Halliwell, B. Biochem. J. 1992, 292, 635-638.
12. Wiseman, H.; Quinn, P.; Halliwell, B. FEBS 1993, 330, 53-56.
13. Guetta, V.; Lush, R. M.; Figg, W. D.; et al. Am. J. Cardiol. 1995, 76, 1072-1073.
14. Steinberg, D.; Parthasarathy, S.; Carew, T. E.; Knoo, J. C.; Witztum, J. L. New Engl. J. Med. 1989, 320, 915-924.
15. Gylling, H.; Pyrhonen, S.; Mantyla, E.; Maenpaa, H.; Kangas, L.; Miettinen, T. A. J. Clin. Oncol. 1995, 13, 2900-2905.
16. Grainger, D. J.; Witchell, C. M.; Metcalfe, J. C. Nature Med. 1995 1, 1067-1073.
17. Morton, R. E.; Zilversmit, D. B. J. Lipid Res. 1982, 23, 1058-1067.
18. Havel, R. J.; Eder, H. A.; Bragdon, J. H. J. Clin. Invest. 1955, 34, 1345-1353.
19. Burstein, M.; Scholnick, H. R.; Morfin, R. J. Lipid Res. 1970, 11, 583-595.
20. Morton; R. E.; Zilversmit, D. B. J. Biol. Chem. 1983, 258, 11751-11757.
21. Pattnaik, N. M.; Zilversmit, D. B. J. Biol. Chem. 1979, 254, 2782-2786.
22. Kuksis, A.; Myher, J. J.; Geher, K.; et al. Arteriosclerosis. 1982, 2, 296-302.
23. Fielding, C. J.; Reaven, G. M.; Liu, G.; Fielding, P. E. Proc. Natl. Acad. Sci. U.S.A. 1984, 81, 2512-2516.
24. Patsch, J. R. Atherosclerosis 1994, 110, S23-S26.
25. Morales, M.; Santana, N.; Soria, A.; et al. Breast Cancer Res. Treat. 1996, 40, 265-270.
26. Miller, G. J.; Miller, N. E. Lancet 1975, 1, 707-714.
27. Engan T.; Krane, J.; Johannessen, D. C.; Lonning, P. E.; Kvinnsland, S. Breast Cancer Res. Treat. 1995, 36, 287-297.
28. Jordan, V. C. Breast Cancer Res. Treat. 1990, 15, 125-136.
29. Morton, R. E.; Parks, J. S. J. Lipid Res. 1996, 37, 1915-1923.